SARS-CoV-2-IN-64

• UNSPSC Description:

  SARS-CoV-2-IN-64 (compound 9), a chenodeoxycholic acid derivative, is a potent inhibitor of spike glycoprotein of SARS-CoV-2[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-in-64.html

• Solubility:

  10 mM in DMSO

• Smiles:

  ClC1=CC=C(C=C1)C(O[C@H]2C[C@]([H])([C@@]3(CC2)C)C[C@H]([C@@]4([C@@]3(CC[C@]5([C@]4(CC[C@@H]5[C@H](C)CCC(OC(C)C)=O)[H])C)[H])[H])OC(C6=CC=C(C=C6)Cl)=O)=O

• Molecular Weight:

  711.75

• References & Citations:

  [1]Gisele Rocha Aguiar, et al. Synthesis and in silico study of chenodeoxycholic acid and its analogues as an alternative inhibitor of spike glycoprotein of SARS-CoV-2. J Biomol Struct Dyn. 2023 Oct-Nov;41(17):8334-8348.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported